Comparative evaluation of negative lymph node count, positive lymph node count, and lymph node ratio in prognostication of survival following completely resection for non-small cell lung cancer: a multicenter population-based analysis
- PMID: 39717353
- PMCID: PMC11663925
- DOI: 10.3389/fsurg.2024.1506850
Comparative evaluation of negative lymph node count, positive lymph node count, and lymph node ratio in prognostication of survival following completely resection for non-small cell lung cancer: a multicenter population-based analysis
Abstract
Objective: Lung cancer is the leading cause of cancer-related mortality. Lymph node involvement remains a crucial prognostic factor in non-small cell lung cancer (NSCLC), and the TNM system is the current standard for staging. However, it mainly considers the anatomical location of lymph nodes, neglecting the significance of node count. Metrics like metastatic lymph node count and lymph node ratio (LNR) have been proposed as more accurate predictors.
Methods: We used data from the SEER 17 Registry Database (2010-2019), including 52,790 NSCLC patients who underwent lobectomy or pneumonectomy, with at least one lymph node examined. Primary outcomes were overall survival (OS) and cancer-specific survival (CSS). Cox regression models assessed the prognostic value of negative lymph node (NLN) count, number of positive lymph node (NPLN), and LNR, with cut-points determined using X-tile software. Model performance was evaluated by the Akaike information criterion (AIC).
Results: The Cox proportional hazards model analysis revealed that NLN, NPLN, and LNR are independent prognostic factors for OS and LCSS (P < 0.0001). Higher NLN counts were associated with better survival (HR = 0.79, 95% CI = 0.76-0.83, P < 0.0001), while higher NPLN (HR = 2.19, 95% CI = 1.79-2.67, P < 0.0001) and LNR (HR = 1.64, 95% CI = 1.79-2.67, P < 0.0001) values indicated worse outcomes. Kaplan-Meier curves for all three groups (NLN, NPLN, LNR) demonstrated clear stratification (P < 0.0001). The NLN-based model (60,066.5502) exhibited the strongest predictive performance, followed by the NPLN (60,508.8957) and LNR models (60,349.4583), although the differences in AIC were minimal.
Conclusions: NLN count, NPLN, and LNR were all identified as independent prognostic indicators in patients with NSCLC. Among these, the predictive model based on NLN demonstrated a marginally superior prognostic value compared to NPLN, with NPLN outperforming the LNR model. Notably, higher NLN counts, along with lower NPLN and LNR values, were consistently associated with improved survival outcomes. The relationship between these prognostic markers and NSCLC survival warrants further validation through prospective studies.
Keywords: NSCLC; SEER; negative lymph node; prognostication; survival.
© 2024 Huang, Chen, Xiao, Chen, He, Xie, Zhao, Xu and Luo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis.Front Surg. 2025 Jan 20;11:1530250. doi: 10.3389/fsurg.2024.1530250. eCollection 2024. Front Surg. 2025. PMID: 39901927 Free PMC article.
-
Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study.Transl Lung Cancer Res. 2020 Aug;9(4):1285-1301. doi: 10.21037/tlcr-20-193. Transl Lung Cancer Res. 2020. PMID: 32953505 Free PMC article.
-
Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.BMJ Open. 2023 Apr 26;13(4):e068044. doi: 10.1136/bmjopen-2022-068044. BMJ Open. 2023. PMID: 37185648 Free PMC article.
-
Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.Lung. 2020 Oct;198(5):839-846. doi: 10.1007/s00408-020-00378-7. Epub 2020 Jul 18. Lung. 2020. PMID: 32683563
-
Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma - A meta-analysis and systematic review.Eur J Surg Oncol. 2021 Jun;47(6):1267-1277. doi: 10.1016/j.ejso.2021.01.004. Epub 2021 Jan 28. Eur J Surg Oncol. 2021. PMID: 33549378
Cited by
-
Lymph node ratio emerges as a pivotal prognostic determinant for cancer-specific survival amidst individuals diagnosed with stage N1 and N2 non-small cell lung carcinoma: A population-based retrospective cohort study.Medicine (Baltimore). 2025 Apr 18;104(16):e42202. doi: 10.1097/MD.0000000000042202. Medicine (Baltimore). 2025. PMID: 40258731 Free PMC article.
References
-
- Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. (2016) 11(1):39–51. 10.1016/j.jtho.2015.09.009 - DOI - PubMed
-
- Occhionorelli S, Andreotti D, Vallese P, Morganti L, Lacavalla D, Forini E, et al. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery. World J Surg Oncol. (2018) 16(1):186. 10.1186/s12957-018-1483-6 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources